Qiagen N.V.
QIAGEN N.V.: Release of a capital market information

QIAGEN N.V. / Share Buy Back

31.07.2018 / 14:03
Dissemination of a Post-admission Duties announcement transmitted by DGAP -
a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

Disclosure according to Article 5 Section (1) and (6) of the EU Regulation
596/2014 in conjunction with Article 2 Section (2) and (3) of the Delegated
EU Regulation 2016/1052 / Share Repurchase - Interim Reporting

With disclosure dated May 15, 2018, QIAGEN N.V. announced pursuant to
Article 5 Section (1) and (6) of the EU Regulation no 596/2014 and Article
2 Section (1) of the Delegated EU Regulation no 2016/1052 the immediate
beginning of a first tranche of up to USD 50 million under the share
repurchase program originally announced on January 31, 2018.

The number of shares which have been bought back on the electronic trading
platform of the Frankfurt Stock Exchange (XETRA) within the framework of
such tranche of the share repurchase program in the time period from July
23, 2018 until and including July 27, 2018 amounts to 66,189 shares.

Shares were bought back as follows:


Date          Number of Shares    Average Price      Purchased Volume (EUR)
              acquired            (EUR)
23-July-2018  13,323              31.2973            416,973.93
24-July-2018  13,261              31.4475            417,025.30
25-July-2018  13,229              31.5211            416,992.63
26-July-2018  13,155              31.6983            416,991.14
27-July-2018  13,221              31.5397            416,986.37
Total         66,189              31.5002            2,084,969.37




The underlying individual trades are published on the website of QIAGEN
N.V. (http://corporate.qiagen.com/investor-relations/share-information/
share-buyback).

The total number of shares which have already been bought back within the
framework of such tranche of the share repurchase program from May 15, 2018
until and including July 27, 2018 amounts to 1,128,958 shares.

The purchase of the shares of QIAGEN N.V. was carried out by a financial
institution that has been commissioned by QIAGEN N.V.

Venlo, 31 July 2018

Managing Board

###
Contacts:

QIAGEN
Investor Relations                     
John Gilardi          
+49 2103 29 11711 
e-mail:ir@qiagen.com                       

Public Relations
Dr. Thomas Theuringer
+49 2103 29 11826
e-mail:pr@qiagen.com


---------------------------------------------------------------------------

31.07.2018 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Archive at www.dgap.de

---------------------------------------------------------------------------

     Language:    English
     Company:     QIAGEN N.V.
                  Hulsterweg 82
                  5912 PL Venlo
                  Netherlands
     Internet:    www.qiagen.com



     End of News    DGAP News Service